Moonlake Immunotherapeutics Forecast and Target Price
$16.7
Moonlake Immunotherapeutics (MLTX) Share Price Forecast
Currently 22 wall-street analysts regularly analyze the financials of Moonlake Immunotherapeutics on a frequent basis to provide recommendations along with target share price. 22 analysts offering 12-month price forecasts for Moonlake Immunotherapeutics (MLTX) have a share price target of $25.86. This median of share price forecast represents a 54.83% upside from the latest price of $16.7 as on 26.03.26.
Moonlake Immunotherapeutics (MLTX) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Moonlake Immunotherapeutics (MLTX) share price will touch around $25.86 in next 12-months.
Moonlake Immunotherapeutics (MLTX) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Moonlake Immunotherapeutics's share price and its median forecast price. As on 26.03.26, the difference is -9.29%
Moonlake Immunotherapeutics (MLTX): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Moonlake Immunotherapeutics (MLTX) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price